Literature DB >> 3002068

Identification of a 65 000 dalton virion envelope protein of human cytomegalovirus.

W J Britt, D Auger.   

Abstract

Human cytomegalovirus (CMV) specific monoclonal antibodies were shown to react with a broadly migrating 65-52 kDa virion envelope protein. These antibodies efficiently neutralized CMV in vitro (greater than 98% plaque reduction), suggesting that this envelope protein was an important target of neutralizing antibodies. This virion envelope protein was shown to be antigenically and electrophoretically distinct from a more abundant 68 kDa virion protein. The relationship between these virion proteins is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002068     DOI: 10.1016/0168-1702(85)90018-8

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  27 in total

1.  Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

Authors:  M Mach; B Kropff; P Dal Monte; W Britt
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus.

Authors:  D R Gretch; B Kari; L Rasmussen; R C Gehrz; M F Stinski
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.

Authors:  Zhongde Wang; Corinna La Rosa; Zhongqi Li; Heang Ly; Aparna Krishnan; Joy Martinez; William J Britt; Don J Diamond
Journal:  Vaccine       Date:  2006-10-06       Impact factor: 3.641

4.  Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150.

Authors:  Ritesh Tandon; Edward S Mocarski
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

5.  Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids.

Authors:  Ritesh Tandon; Edward S Mocarski
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses.

Authors:  R Lehner; H Meyer; M Mach
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex.

Authors:  M T Huber; T Compton
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly.

Authors:  V Sanchez; K D Greis; E Sztul; W J Britt
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  Strain-specific neutralization of human cytomegalovirus isolates by human sera.

Authors:  M Klein; K Schoppel; N Amvrossiadis; M Mach
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines.

Authors:  Zhongde Wang; Joy Martinez; Wendi Zhou; Corinna La Rosa; Tumul Srivastava; Anindya Dasgupta; Ravindra Rawal; Zhongqui Li; William J Britt; Don Diamond
Journal:  Vaccine       Date:  2009-12-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.